0

NDGA - CAS 500-38-9

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP500389-A
CAS500-38-9
Structure
Molecular Weight302.36
DescriptionA cell-permeable antioxidant and a selective lipoxygenase (LOX) inhibitor (IC₅₀ = 200 nM, 30 µM, and 30 µM for 5-LOX, 12-LOX, and 15-LOX, respectively) over cyclooxygenase (IC₅₀ = 100 µM).
SolubilityDMSO: 10 mg/mL; ethanol: soluble
Assay≥90% (HPLC)
Formcrystalline solid
Size250MG
Storage Conditions+15C to +30C
1

Effects of BX661A, a New Therapeutic Agent for Ulcerative Colitis, on Reactive Oxygen Species in Comparison With Salazosulfapyridine and Its Metabolite Sulfapyridine

I Kimura, T Kumamoto, A Matsuda, M Kataoka, Y Kokuba

Arzneimittelforschung. 1998 Oct;48(10):1007-11.

PMID: 9825118

1

Protective Effect of Nordihydroguaiaretic Acid (NDGA) Against Norgestrel Induced Genotoxic Damage

Yasir Hasan Siddique, Tanveer Beg, Mohammad Afzal

Toxicol In Vitro. 2006 Mar;20(2):227-33.

PMID: 16061348

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode